Search
for
Sort by
Research 241–270 of 1000+
- Cemiplimab-Induced Alopecia Areata
- Pathologic Quiz Case: A Cutaneous Nodule on the Left Temple
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Redefining the Skin Barrier: A Microbiome‐Integrated Multilayered Defense Model
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Pathophysiology of the Behçet's Disease
- A “hair‐raising” history of alopecia areata
- Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.
- Folate receptor β performs an immune checkpoint function in activated macrophages
- Alopecia Areata. Current situation and perspectives
- Cutaneous Lupus Erythematosus
- Mechanism of PPARα agonist in alopecia areata
- Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway
- Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin
- Unveiling the Potential of Single‐Cell Encapsulation in Biomedical Applications: Current Advances and Future Perspectives
- A novel chitosan-peptide system for cartilage tissue engineering with adipose-derived stromal cells
- Tregs: Where We Are and What Comes Next?
- In This Issue
- Exploiting Unique Features of Microneedles to Modulate Immunity
- MicroRNA in skin diseases
- Myeloproliferative disorder associated with alopecia universalis
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ
- The role of WNT10B in physiology and disease: A 10-year update
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects